Can AVGO Stock Live Up To Its Multiple?

This is a year of extreme acceleration for Broadcom (AVGO). The company’s engine is its deep, multi-year collaboration to build custom AI chips for just six strategic customers.

That AI-specific business is surging, while the company’s other semiconductor and software segments remain largely flat. To secure this growth, management has pre-emptively locked in its supply of critical components for the next several years.

That’s the story the market is currently paying 91.4x trailing earnings for. Has it taken the multiple too far, or is the growth implied by today’s price reasonable? Let’s unpack below.

Before we get into the math behind that valuation, AVGO’s current numbers are worth keeping in mind as a reference point:

LTM refers to last twelve months.

What The Price Is Asking For

Justifying the current market cap over the next 6 years would require three assumptions to materialize. 1. The multiple settles from today’s 91.4x toward 25.2x, where mature, leading-edge semiconductor businesses typically clear. 2. Margins land near 34.4%, anchored on the company’s own track record, which already runs at or above what mature peers earn. 3. And revenue compounds from $68.3B today to $263.1B at maturity, supporting $90.6B of annual net income. That last line works out to a required revenue CAGR of 25.2%, roughly in line with the 25.2% the business is currently running.

Is This Realistic?

Broadcom’s leadership in networking and silicon design allows its partners to build more efficient data centers. Its VMware software is also positioned as an essential, non-replaceable layer for managing that complex hardware.

A significant portion of the company’s AI growth relies on sustained spending from these key customers. A pause in hyperscaler investment could pose a material headwind to Broadcom’s projected growth trajectory.

The required pace matches the current trajectory. Continuity is the bet, and historically, stocks trading at premium multiples experience heightened volatility following a soft quarter.

Success hinges on becoming an inseparable part of its few key customers’ strategic road maps, not just another supplier.

Should You Invest In Broadcom?

Reverse-engineering the growth baked into today’s high multiples reveals a thin margin for error. A single-stock thesis at these valuations is inherently fragile. As historical volatility shows, relying on the priced-for-perfection math of one position ignores the structural risk that high-multiple names face during broader market inflections.

The Trefis High Quality (HQ) Portfolio combines analytical rigor with a forward-looking view across 30 stocks, with a consistent selection framework and sizing/re-balancing discipline designed to deliver upside without the single-name risk you just read through here.

By selecting 30 high-conviction stocks, the HQ strategy has historically outpaced the S&P 500, S&P Mid-cap, and Russell 2000.